Xiao Xiao is the founder of Belief Biomed. Belief Biomed has raised $271M in total funding. Latest round: Series C. Backed by Qiming Venture Partners.
Xiao Xiao is the Co-founder, Chairman, and Chief Science Officer of Belief BioMed. The company focuses on cutting-edge gene therapy, with a product pipeline covering rare and common diseases. Belief BioMed successfully launched China's first gene therapy for Hemophilia B, BBM-H901, in 2025. They are also developing BBM-H803, an AAV-based gene therapy for Hemophilia A, which they are partnering with Grand Life Sciences to commercialize in Greater China.
Full founder directory · Investor directory · Company funding database · Fundraising library